1480
METHODS
Patients
After obtaining approval from the ethics committee
and informed consent, 20 consecutive patients scheduled to undergo liver transplantation for acute or
Vol. 106, No. 5, May 2008
Perioperative Management
Patients were anesthetized with sufentanil and propofol. Cisatracurium was used for muscle relaxation.
Sufentanil and isoflurane were used for maintenance of
anesthesia. After the induction of anesthesia, the patients trachea was intubated and mechanical ventilation
was instituted using volume-controlled ventilation. All
patients lungs were ventilated with an oxygen-air mixture to maintain an arterial oxygen partial pressure
above 13.3 kPa, and ventilation parameters were adjusted to ensure an arterial carbon dioxide partial pressure between 4.7 and 5.4 kPa.
Liver transplantation was accomplished without
venovenous bypass using the three-phase piggyback.17 First, the attachments of the diseased liver
were resected, and the vascular structures were prepared for resection. The second or anhepatic phase
extends from the time when the host liver was removed until the donor liver was revascularized. Finally, the graft was reperfused.
After liver transplantation, patients were admitted
to the intensive care unit (ICU). Patients were sedated
with propofol and sufentanil, and mechanical volumecontrolled ventilation was continued for a minimum
4 h period.
Cardiopulmonary Monitoring
After the induction of anesthesia and just before the
beginning of surgery, a PAC (CCOmbo, 744HF75, 7.5
Fr, Edwards Lifesciences) was inserted via the left
subclavian vein through an introducer (M3L9FHSI, 9
Fr, Edwards Lifesciences) and was connected to the
Vigilance monitor (Edwards Lifesciences) for CO
monitoring. The position of the catheter was confirmed by pressure curves, -pulmonary artery occlusion pressure/-pulmonary artery pressure (PAP) ratio
as previously described18 and postoperatively by
chest radiograph. Intracardiac pressure and PAP were
monitored continuously. A safe level of heat was
transferred to the blood by a computer-controlled
thermal filament mounted on the PAC.3 To eliminate
the natural temperature variations in the pulmonary
artery, which could constitute background thermal
noise, heat was transferred to the blood in a pseudorandom on off fashion.3,19 The observed changes in
pulmonary artery temperature were recorded by the
distal rapid-response thermistor in the pulmonary
Vol. 106, No. 5, May 2008
APCO Monitoring
A 3 Fr, 8-cm-long arterial catheter (115.09, Vygon,
Ecouen, France) was inserted in the left radial artery.
A dedicated transducer was connected to the radial
arterial line for APCO evaluation (Vigileo System,
FloTrac, Edwards Lifesciences). This system needs
no external calibration and provides CCO measurements from the arterial pressure wave. The Vigileo
(Software version 1.07) records hemodynamic variables at 20-s intervals, performing its calculations on
the most recent 20 s data. The system calculates the
stroke volume (SV) using arterial pulsatility (standard
deviation of the pulse pressure over a 20-s interval),
resistance, and compliance (Eq. 1). The CO is calculated as follows: CO heart rate SV.
(1)
Study Protocol
Fifteen sets of measurements were performed in the
operating room after the induction of anesthesia: 5, 15,
and 25 min after PAC insertion (T13); 5, 15, and 25
min after portal clamping (T4 6); 15, 25, and 35 min
after the hepatectomy (T79); and 10, 20, 30, 40, 50,
and 60 min after reperfusion (T10 15). Five sets of
measurements were made in the ICU: 60, 90, 120, 150,
and 180 min after the admission (T16 20). Each set of
measurements was made with the patient in the
supine position and during a steady-state period, i.e.,
at least 5 min after a change in infusion rate of
catecholamine or sedative drugs, or ventilatory settings. At each time point, three consecutive measurements of ICOSM were performed and the plausibility
of every temperature curve was judged visually on the
Vigilance monitor. If ICOSM changed by more than
2008 International Anesthesia Research Society
1481
Child-Pugh A
Child-Pugh B
Child-Pugh C
60
89 (20)
0.33 (0.28)
1414 (454)
4.5 (1.1)
4.4 (1.0)
36.1
200
77 (16)*
0.28 (0.27)
1059 (339)*
5.5 (1.8)*
5.8 (1.7)
36.2
140
72 (16)*
0.49 (0.54)*
634 (235)*
8.3 (2.1)*
8.5 (2.0)*
36.1
15% during the steady-state period, five measurements were performed and the highest and lowest
were rejected. For each measurement of ICOSM, a
corresponding simultaneous APCO was recorded.
The average of the consecutive measurements of
ICOSM and APCO was used for statistical analysis.
CCO was not used for statistical analysis.
Hemodynamic data were grouped into five phases:
after PAC insertion (3 measurements), after portal
clamping (3 measurements), after hepatectomy (3
measurements), after reperfusion (6 measurements),
and in the ICU (5 measurements).
ICOSM and APCO measurements were obtained by
two operators who were blinded to the corresponding
CO measurement of the other method.
Statistical Analysis
All results were expressed as mean standard
deviation (sd) unless indicated otherwise. APCO and
ICOSM were compared using the Bland and Altman
method.22 Bias (mean difference between APCO and
ICOSM) represents the systematic error between both
methods. Precision (sd of the bias) is representative of
the random error or variability between the different
techniques. The limits of agreement were calculated as
bias 2sd, and defined the range in which 95% of the
differences between the methods were expected to lie.
The percentage error was calculated as the ratio of
2sd of the bias to mean CO and was considered
clinically acceptable if it was below 30%, as proposed
by Critchley and Critchley.23
Bias, limits of agreements, and percentage error
between ICOSM and APCO were calculated for all
data, separately for the five phases (PAC insertion,
after portal clamping, after hepatectomy, after reperfusion, and after arrival in ICU) and separately for
different Child-Pugh grades (A, B, and C). The relation
between systemic vascular resistance (SVR) and the
bias between ICOSM and APCO were tested using a
logarithmic regression. Changes in CO (-CO) were
calculated as the differences between consecutive
measurements. The ability to detect -CO was tested
using the BlandAltman method. Child-Pugh grade
A, B, and C patient data were compared using a
Students t-test. All statistical analysis was computed
1482
RESULTS
Twenty patients (6 women, 14 men) were enrolled.
Their average age was 51 9 yr, average weight was
63 12 kg, and average height was 170 9 cm. The
average body surface area was 1.80 0.16 m2. Surgical
indications were hepatitis C virus cirrhosis (n 6),
hepatitis B virus cirrhosis (n 1), alcoholic cirrhosis
(n 11), and others (n 2). The Child-Pugh classification was A, B, and C, respectively, for 3, 10, and 7
patients. The average Model for End-Stage Liver Disease score was 16 5, and the average packed red blood
cell transfusion was 6 4 U. Mean anesthesia time was
7.5 2 h. Four-hundred comparative measurements
performed between ICOSM and APCO were obtained.
No data were rejected. ICOSM values ranged from 2.5 to
12.3 L/min (mean 6.4 2.3 L/min) whereas the values
for APCO ranged from 2.1 to 9.5 L/min (mean 5.5 1.3
L/min). All patients received norepinephrine (0.36
0.40 g kg1 min1). Hemodynamic data are shown in
Table 1. No adverse effect related to PAC was observed.
Global Analysis
The bias between ICOSM and APCO was 0.8 L/min,
and 95% limits of agreement were 1.8 to 3.5 L/min
(Fig. 1). The percentage error between all ICOSM and
APCO measurements was 43%. Bias between ICOSM
and APCO was correlated with SVR [r2 0.55; P
0.0001; y 15.8 2.2 ln(x)] (Fig. 2). Delta-CO was
calculated separately for each method and data comparison revealed a bias of 0.1 L/min; 95% limits of
agreement were 2.4 to 2.7 L/min.
Subgroup Analysis
Bias, limits of agreements, and percentage error of
the five phases are shown in Table 2. Bias between
Delta-ICOSM and Delta-APCO were not different in
the five phases.
Bias, limits of agreements, and percentage error in
different Child-Pugh grades are shown in Table 3. ChildPugh A patients presented a percentage error 30% and
a bias between ICOSM and APCO significantly lower
than Child-Pugh B and C patients (Fig. 3).
ANESTHESIA & ANALGESIA
DISCUSSION
In the present study, APCO values differed significantly from ICOSM values in patients undergoing liver
transplantation. We found a bias of 0.8 L/min, 95%
limits of agreement of 1.8 to 3.5 L/min. The percentage
error was 43%, exceeding a 30% limit of acceptability.
Recently published studies investigating the
Vigileo/FloTrac showed discordant results (Table 4).
Studies performed in patients undergoing cardiac
surgery, liver transplantation, or in patients with
septic shock found clinically unacceptable bias and
limits of agreement between APCO and ICOTD, and
between APCO and COTPT.1214,24,25 However, three
other cardiosurgical studies found clinically acceptable bias and limits of agreement between APCO and
ICOTD or between APCO and COTPT.11,26,27 De Waal et
al. reported a mean bias of 0.00 L/min (sd 0.87)
between APCO and COTPT in 22 patients studied after
cardiac surgery.27 Button et al. showed that performance of the Vigileo/FloTrac, the PiCCOplus and
the Vigilance CCO monitor for CO measurement were
comparable when tested against ICOTD in 31 patients
undergoing cardiac surgery.26 Manecke et al. studied
50 postoperative cardiac surgery patients and found
that APCO algorithm provided CO assessments that
agreed satisfactorily for clinical purposes with intermittent thermodilution.11 The bias and the precision
were, respectively, 0.55 and 0.98 L/min between
APCO and ICOTD. The authors did not calculate the
percentage error as proposed by Critchley and Critchley and were unable to conclude whether the results
were clinically acceptable.
Table 2. Bias, 95% Limits of Agreement, and Percentage Error Between ICOSM and APCO Measurements at Different Phases of
Liver Transplantation
After PAC
insertion
Portal clamping
Anhepathy
Graft reperfusion
Intensive
care unit
0.7 (1.4)
3.6 to 2.1
54
0.9 (1.5)
2.0 to 3.7
52
0.7 (1.1)
1.5 to 2.9
40
1.2 (1.4)
1.7 to 3.9
43
0.6 (1.3)
1.9 to 3.1
39
Table 3. Bias, 95% Limits of Agreement, and Percentage Error Between ICOSM and APCO Measurements in Patients with
Child-Pugh Grade A, B, and C
Bias (sd) (L/min)
95% limits of agreement (L/min)
Percentage error (%)
Child-Pugh A
Child-Pugh B
Child-Pugh C
0.025 (0.34)
0.64 to 0.69
15
0.43 (1.1)*
1.7 to 2.6
40
1.8 (1.46)*
1.1 to 4.7
40
1483
Table 4. Studies Comparing Data Obtained with Vigileo/FloTrac to Those Obtained with PAC or Transpulmonary Thermodilution
Authors Patients Measurements
Costa
et al.24
Opdam
et al.13
Mayer
et al.12
16
Sakka
et al.25
de Waal
et al.27
Manecke
et al.11
24
6
40
22
50
Model
Bias
PE
Cardiac
output (BTD)
Cardiac
index (BTD
and CCI)
Cardiac
index (BTD)
Liver
0.87 L/min
transplantation
Cardiac surgery 0.0057 L/min/m2
Cardiac surgery
0.46 L/min/m2
Cardiac
output (TPT)
Cardiac
output (TPT)
Cardiac
output (BTD)
Septic shock
0.5 L/min
Cardiac surgery
0.00 L/min
r 0.75
33%
Cardiac surgery
0.55 L/min
r2 0.27
r 0.53
(P 0.0001)
r2 0.26
Precision 2.3 L/min
PAC pulmonary arterial catheter; BTD bolus thermodilution; CCI continuous cardiac index; TPT transpulmonary thermodilution; PE percentage error.
REFERENCES
1. Pirat A, Sargin D, Torgay A, Arslan G. Identification of preoperative predictors of intraoperative blood transfusion requirement in orthotopic liver transplantation. Transplant Proc
2002;34:215355
2. Schroeder R, Collins B, Tuttle-Newhall E, Robertson K, Plotkin
J, Johnson L, Kuo P. Intraoperative fluid management during
orthotopic liver transplantation. J Cardiothorac Vasc Anesth
2004;18:438 41
3. Yelderman M, Quinn MD, McKown RC. Thermal safety of a
filamented pulmonary artery catheter. J Clin Monit 1992;8:1479
4. Boldt J, Menges T, Wollbruck M, Hammermann H, Hempelmann G. Is continuous cardiac output measurement using
thermodilution reliable in the critically ill patient? Crit Care
Med 1994;22:1913 8
5. Bottiger BW, Soder M, Rauch H, Bohrer H, Motsch J, Bauer H,
Martin E. Semi-continuous versus injectate cardiac output measurement in intensive care patients after cardiac surgery. Intensive Care Med 1996;22:312 8
6. Bowdle TA. Complications of invasive monitoring. Anesthesiol
Clin North Am 2002;20:571 88
7. Gnaegi A, Feihl F, Perret C. Intensive care physicians insufficient knowledge of right-heart catheterization at the bedside:
time to act? Crit Care Med 1997;25:21320
8. Iberti TJ, Fischer EP, Leibowitz AB, Panacek EA, Silverstein JH,
Albertson TE. A multicenter study of physicians knowledge of
the pulmonary artery catheter. Pulmonary Artery Catheter
Study Group. JAMA 1990;264:2928 32
9. Jain M, Canham M, Upadhyay D, Corbridge T. Variability in
interventions with pulmonary artery catheter data. Intensive
Care Med 2003;29:2059 62
10. Manecke GR. Edwards FloTrac sensor and Vigileo monitor:
easy, accurate, reliable cardiac output assessment using the
arterial pulse wave. Expert Rev Med Devices 2005;2:5237
11. Manecke GR Jr, Auger WR. Cardiac output determination from
the arterial pressure wave: clinical testing of a novel algorithm
that does not require calibration. J Cardiothorac Vasc Anesth
2007;21:37
12. Mayer J, Boldt J, Schollhorn T, Rohm KD, Mengistu AM, Suttner
S. Semi-invasive monitoring of cardiac output by a new device
using arterial pressure waveform analysis: a comparison with
intermittent pulmonary artery thermodilution in patients undergoing cardiac surgery. Br J Anaesth 2007;98:176 82
13. Opdam HI, Wan L, Bellomo R. A pilot assessment of the FloTrac
cardiac output monitoring system. Intensive Care Med
2007;33:344 9
14. Sander M, Spies CD, Grubitzsch H, Foer A, Muller M, von
Heymann C. Comparison of uncalibrated arterial waveform
analysis in cardiac surgery patients with thermodilution cardiac
output measurements. Crit Care 2006;10:R164
15. Child CG, Turcotte JG. Surgery and portal hypertension. Major
Probl Clin Surg 1964;1:1 85
16. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams
R. Transection of the oesophagus for bleeding oesophageal
varices. Br J Surg 1973;60:646 9
2008 International Anesthesia Research Society
1485
1486